Context Therapeutics Inc.

Contributing Author

Recent Articles by Context Therapeutics Inc.

Jun-02	Context Therapeutics Announces CTIM-76 Trial in Progress Poster Presentation at 2025 ASCO Meeting CNTX GlobeNewswire
May-29	Context Therapeutics to Appoint Dr. Karen Chagin, M.D. as Chief Medical Officer CNTX GlobeNewswire
May-12	Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) CNTX GlobeNewswire
May-07	Context Therapeutics Reports First Quarter 2025 Operating and Financial Results CNTX GlobeNewswire
May-05	Context Therapeutics Announces Chief Medical Officer Transition CNTX GlobeNewswire